Editorial
doi: 10.1200/JCO.2009.26.3996.
Epub 2010 Jan 25.
Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma
- PMID: 20100955
- DOI: 10.1200/JCO.2009.26.3996
Item in Clipboard
Editorial
Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma
J Clin Oncol.
.
No abstract available
Comment in
-
Fcgamma receptor polymorphisms as biomarkers for epidermal growth factor receptor antibodies.J Clin Oncol. 2010 Aug 10;28(23):e393; author reply e394-6. doi: 10.1200/JCO.2010.28.7342. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20547983 No abstract available.
Similar articles
-
Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study.Eur J Cardiothorac Surg. 2010 Jul;38(1):34-7. doi: 10.1016/j.ejcts.2010.01.023. Epub 2010 Mar 28. Eur J Cardiothorac Surg. 2010. PMID: 20353893
-
Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer.J Surg Oncol. 2014 Aug;110(2):97-8. doi: 10.1002/jso.23648. Epub 2014 Jun 4. J Surg Oncol. 2014. PMID: 24895315 No abstract available.
-
Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.Oncogene. 2009 Aug;28 Suppl 1:S38-45. doi: 10.1038/onc.2009.200. Oncogene. 2009. PMID: 19680295 Review.
-
Predicting non-small cell lung cancer expression of epidermal growth factor receptor and matrix metalloproteinase 9 from immunohistochemical staining of diagnostic biopsy samples.Eur J Cancer. 2004 Jul;40(10):1589-92. doi: 10.1016/j.ejca.2004.02.022. Eur J Cancer. 2004. PMID: 15196544
-
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.J Clin Pathol. 2006 Aug;59(8):790-800. doi: 10.1136/jcp.2005.031351. J Clin Pathol. 2006. PMID: 16873561 Free PMC article. Review.
Cited by
-
Accuracy of Cytology Specimen and Needle Core Biopsies for Detection of KRAS Mutation in Non-Small Cell Carcinoma: Comparison With Resection Specimen.World J Oncol. 2011 Dec;2(6):275-280. doi: 10.4021/wjon416w. Epub 2011 Dec 19. World J Oncol. 2011. PMID: 29147262 Free PMC article.
-
Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer.Med Oncol. 2014 Aug;31(8):86. doi: 10.1007/s12032-014-0086-5. Epub 2014 Jun 24. Med Oncol. 2014. PMID: 24958519
-
[Personalized targeted therapy for lung cancer].Zhongguo Fei Ai Za Zhi. 2013 Aug 20;16(8):C21-34. doi: 10.3779/j.issn.1009-3419.2013.08.10. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23945250 Free PMC article. Review. Chinese.
-
Personalized targeted therapy for lung cancer.Int J Mol Sci. 2012;13(9):11471-11496. doi: 10.3390/ijms130911471. Epub 2012 Sep 13. Int J Mol Sci. 2012. PMID: 23109866 Free PMC article. Review.
-
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.Br J Cancer. 2011 Jan 4;104(1):68-74. doi: 10.1038/sj.bjc.6605972. Epub 2010 Nov 23. Br J Cancer. 2011. Retraction in: Br J Cancer. 2012 Dec 4;107(12):2024. doi: 10.1038/bjc.2012.497. PMID: 21102589 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
